Houston Methodist Neurological Institute researchers from the department of neurosurgery shrunk a deadly glioblastoma tumor by more than a third using a helmet generating a noninvasive oscillating magnetic field that the patient wore on his head while administering the therapy in his own home. The 53-year-old patient died from an unrelated injury about a month into the treatment, but during that short time, 31% of the tumor mass disappeared. The autopsy of his brain confirmed the rapid response to the treatment.
“Thanks to the courage of this patient and his family, we were able to test and verify the potential effectiveness of the first noninvasive therapy for glioblastoma in the world,” said David S. Baskin, M.D., FACS, FAANS, corresponding author and director of the Kenneth R. Peak Center for Brain and Pituitary Tumor Treatment in the Department of Neurosurgery at Houston Methodist. “The family’s generous agreement to allow an autopsy after their loved ones’ untimely death made an invaluable contribution to the further study and development of this potentially powerful therapy.”
In a case study published in Frontiers in Oncology Baskin and his colleagues detailed the journey of their pioneering patient who suffered from end-stage recurrent glioblastoma, despite a radical surgical excision, chemoradiotherapy and experimental gene therapy.
Glioblastoma is the deadliest of brain cancers in adults, nearly always fatal, with a life expectancy of a few months to two years. When the patient’s glioblastoma recurred in August 2019, Baskin and his team, already working on the OMF treatment in mouse models, received FDA approval for compassionate use treatment of the patient with their newly invented Oncomagnetic Device under an Expanded Access Program (EAP). The protocol also was approved by the Houston Methodist Research Institute Institutional Review Board.
The treatment consisted of intermittent application of an oscillating magnetic field generated by rotating permanent magnets in a specific frequency profile and timing pattern. First administered for two hours under supervision in the Peak Clinic, ensuing treatments were given at home with help from the patient’s wife, with increasing treatment times up to a maximum of only six hours per day.
The Oncomagnetic Device looks deceptively simple: three oncoscillators securely attached to a helmet and connected to a microprocessor-based electronic controller operated by a rechargeable battery, an invention by case study co-author Dr. Santosh Helekar. During the patient’s five weeks of treatment, the magnetic therapy was well-tolerated and the tumor mass and volume shrunk by nearly a third, with shrinkage appearing to correlate with the treatment dose.
“Imagine treating brain cancer without radiation therapy or chemotherapy,” said Baskin. “Our results in the laboratory and with this patient open a new world of non-invasive and nontoxic therapy for brain cancer, with many exciting possibilities for the future.”
More from: Houston Methodist Hospital
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
- Israeli Doctors Have Made a Potential Medical Breakthrough for Brain Cancer Thanks to a 3D-Printed Tumoron August 23, 2021 at 5:01 pm
Researchers at Tel Aviv University have successfully made an active and viable 3D-printed glioblastoma tumor, which they hope will help with treatment.
- ICL fluorescent label homogenously penetrates the glioblastoma brain tumorson August 23, 2021 at 4:41 pm
Fluorescent indocarbocyanine lipid (ICL) shows much better distribution within glioblastoma brain tumors compared to fluorescent phospholipids, according to a study published in ACS Nano.
- Focus Atlanta - HWPLon August 23, 2021 at 11:54 am
Heavenly Culture World Peace Restoration of Light provides thank you notes to essential healthcare workers during the pandemic.
- Focus Atlanta - Glioblastoma Foundationon August 23, 2021 at 11:25 am
The Executive Director of the Glioblastoma Foundation stopped by to give us insight on research and trial options for the rare brain tumor.
- Why is this Israeli lab 3D printing deadly Glioblastoma tumours?on August 20, 2021 at 9:38 am
Researchers in Tel Aviv are using MRIs, CT scans and cells from patients suffering from Glioblastoma to 3D print tumours to find new treatments.
Go deeper with Google Headlines on:
Go deeper with Bing News on:
Oscillating magnetic field
- sixth senseon August 10, 2021 at 4:59 pm
Ear implants are the next most useful because oscillating magnetic fields can be translated to sound. For some, this is merely a parlor trick. Lifting paper clips and messing with a compass are ...
- Audeze debuts its CRBN electrostatic headphoneon August 3, 2021 at 11:23 am
The ribbon carries the electrical audio signal, which creates a corresponding oscillating magnetic field that interacts with the static magnetic field of the stators, pushing the diaphragm back ...
- New Investigational Helmet Device Shrinks Glioblastomaon July 29, 2021 at 5:00 pm
A case report describes a novel helmet device that generates a noninvasive oscillating magnetic field and that shrunk a glioblastoma tumor by about a third. This is the first time that the ...
- All-Metal Separators Use Three-Coil Systemon July 27, 2021 at 4:59 pm
The Met-Sep BULK series of all-metal separators from T&T Technology is designed to separate both non-magnetic metals and magnetic ... a high frequency signal and transmits an oscillating electric ...
- Strange looking magnetic helmet shrinks glioblastoma in human trialson July 27, 2021 at 3:05 am
The treatment consists of the intermittent application of an oscillating magnetic field generated by rotating permanent magnets in a specific frequency profile and with a specific timing pattern.